Wegovy 1.7 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26FD2VS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,095
Award facts
- Contract value 100% obligated
- $17,094.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $17,094.88 to AmerisourceBergen Drug Corp for the supply of Wegovy (semaglutide) 1.7 mg/0.75 mL pens on January 21, 2026, with completion scheduled for January 22, 2026. This delivery order was competitively awarded with no set-aside designation and is performed at the contractor's facility in Conshohocken, Pennsylvania. The award is executed under AmerisourceBergen's parent company Cencora, Inc., which holds a substantial $999.99 billion indefinite delivery contract with DLA Troop Support Medical through December 2031, serving as the primary vehicle for pharmaceutical and medical supply delivery to military healthcare systems globally.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, supplying a comprehensive range of medications and medical supplies to support military treatment facilities and veteran healthcare programs. The contractor's extensive portfolio includes specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This specific delivery order for Wegovy, a GLP-1 receptor agonist used in diabetes and weight management treatment, reflects the contractor's ongoing role in providing prescription medications to support the Defense Health Agency and other federal healthcare customers through flexible and competitively awarded contract vehicles.
Quick answers
Who was awarded contract SPE2DR26FD2VS?
SPE2DR26FD2VS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FD2VS worth?
The government has obligated $17,095 on SPE2DR26FD2VS.
Is contract SPE2DR26FD2VS an order under another contract?
Yes. SPE2DR26FD2VS is a delivery order under SPE2DR25D2203, an indefinite delivery contract.
Was contract SPE2DR26FD2VS competed?
The extent of competition for SPE2DR26FD2VS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award